Latest Induced pluripotent stem cell Stories
Study produces unprecedented model to study intestinal diseases CINCINNATI, Oct.
A year after its formation in September 2013, Boston’s Adult Stem Cell Technology Center, LLC (ASCTC) was invited to present its commercialization plans and progress at the 7th Annual BioPharm
A study published in STEM CELLS on August 30, 2014, details a new, simple, and highly efficient way to convert cells taken from an adult’s skin into stem cells that have the potential to differentiate
In a new study published in STEM CELLS Translational Medicine on July 14, 2014, researchers from Tokyo Medical and Dental University along with a team from Osaka University may have found a potentially
Computer algorithm also provides 'quality assurance' for lab-created cells BOSTON, Aug.
Recent studies have shown that transplanting induced pluripotent stem cell-derived neural stem cells (iPS-NSCs) can promote functional recovery after spinal cord injury in rodents and non-human primates.
The Adult Stem Cell Technology Center, LLC in Boston Massachusetts has more adult stem cell intellectual property than it requires for its own current business development plans.
Many current regenerative medicine trials are based on heterologous stem cell transplantation, in which stem cells multiplied from one type of organ or tissue are transferred to treat diseases,
researchers have found a gene that could be key to the development of stem cells – cells that can potentially save millions of lives by morphing into practically any cell in the body.
According to a new report from BCC Research, the global market for induced pluripotent stem cells (iPSCs) is expected to grow to $2.9 billion by 2018, with a five-year compound annual growth rate